Print

Orchid Chemicals & Pharmaceuticals Ltd.
Unaudited Financial Results for three months ended June 30, 2008
(Rs.Lakhs)
   
Standalone Accounts
Consolidated Accounts
S.No
Particulars
Three months ended
30-June-08
(Unaudited)
Three months ended
30-June-07
(Unaudited)
Year ended 31-Mar-08 (Audited)
Three months ended 30-June-08 (Unaudited)
Three months ended 30-June-07 (Unaudited)
Year ended 31-Mar-08 (Audited)
1
 Sales and Operating Income
28,765.92
23,597.24
123,891.62
30,993.43
24,954.57
130,096.39
2
 Other Income
1,866.74
30.09
124.20
1,836.59
-
3.70
3
 Total Income
30,632.66
23,627.33
124,015.82
32,830.02
24,954.57
130,100.09
4
Total Expenditure
a) Decrease/(Increase) in Stock in trade
(5,656.16)
(3,190.97)
(1,933.77)
(4,492.34)
(3,676.10)
(2,530.48)
b) Material Cost
14,344.91
9,288.67
42,829.35
14,865.77
10,756.15
47,892.95
c) Purchase of Traded Goods
996.57
843.97
2,569.32
996.57
843.97
2,569.33
d) Staff Cost
2,874.81
2,227.48
9,989.76
3,167.85
2,611.77
11,714.19
e) Depreciation / Amortisation
3,117.64
2,298.76
9,766.78
3,213.21
2,359.74
10,067.84
f) Other Expenditure
9,239.20
7,836.89
35,954.29
9,577.66
7,983.19
36,456.39
g) Total
24,916.97
19,304.80
99,175.73
27,328.72
20,878.72
106,170.22
5
Profit from Ordinary Activities before Interest & Exceptional Item (3-4)
5,715.69
4,322.53
24,840.09
5,501.30
4,075.85
23,929.87
6
 Interest and Finance Charges
3,024.48
2,017.86
8,112.63
3,030.29
2,041.04
8,200.04
7
 Profit from Ordinary Activities before Exceptional Item (5-6)
2,691.21
2,304.67
16,727.46
2,471.01
2,034.81
15,729.83
8
 Exceptional Item
(5,879.72)
5,286.18
7,126.67
(5,879.72)
5,286.18
7,126.67
9
 Profit/(Loss) before Tax after Exceptional item (7+8)
(3,188.51)
7,590.85
23,854.13
(3,408.71)
7,320.99
22,856.50
10
 Tax expenses
 - Current Tax & Deferred Tax
(58.91)
2,420.05
5,250.52
(58.91)
2,420.05
5,163.51
 - Fringe Benefit Tax
35.00
41.00
150.00
35.00
42.00
159.00
11
 Net Profit/(Loss) After Tax (9-10)
(3,164.60)
5,129.80
18,453.61
(3,384.80)
4,858.94
17,533.99
12
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
6,587.66
6,582.24
6,585.08
6,587.66
6,582.24
6,585.08
13
 Reserves excluding Revaluation Reserves
-
-
59,912.92
14
 Basic Earnings per Share (EPS) Rs.
-4.80*
7.79*
28.03
-5.14*
7.38*
26.63
15
 Diluted Earnings per Share (EPS) Rs.
-4.80*
5.23*
18.85
-5.14*
4.96*
17.91
16
Aggregate of Public Shareholding
 

-Number of equity shares
55522404
50208204
55398604
  -Percentage of Shareholding
84.28
76.28
84.13
* EPS is for the period (not annualised)
  • The above financial results were taken on record by the Board of Directors at its meeting held on Wednesday, July 30, 2008.
  • The Company is operating in single segment (i.e) "Pharmaceuticals".
  • Exceptional items represent exchange loss on FCCB
  • During the quarter, the wholly-owned subsidiary Orchid Pharma Japan KK was incorporated.
  • The Allotment Committee of the Board has allotted shares as follows:
    -7525 shares (7400 shares at an adjusted price of Rs.200.44 per share and 125 shares at a revised price of Rs.193.25 per share) to employees under ORCHID ESOP 1999 Scheme and 1900 equity shares at a price of Rs.193.25 per share under ORCHID ESOP 2005 Scheme, on April 26, 2008.
    '-16175 shares (16150 shares at an adjusted price of Rs.200.44 per share and 25 shares at a revised price of Rs.193.25 per share) to employees under ORCHID ESOP 1999 Scheme and 200 equity shares at a price of Rs.193.25 per share under ORCHID ESOP 2005 Scheme, on May 29, 2008.
  • The Company received 6 complaints during the quarter ended June 30, 2008 from the shareholders. All the complaints have been resolved and no complaints were pending as on June 30, 2008
  • The above results except for the figures relating to Consolidated results have been subjected to limited review by the Statutory Auditors.
  • Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : July 30, 2008

For and on behalf of the Board

K.Raghavendra Rao
Managing Director